Literature DB >> 6722705

The use of intravenous chlorimipramine in the treatment of obsessive compulsive disorder.

L B Warneke.   

Abstract

Obsessional disorder has always remained a difficult illness for psychiatrists to treat with response to therapy, both psychotherapy and chemotherapy, being low. A review of the traditional approaches to the treatment of obsessional disorder is done, including a brief review of the literature on intravenous chlorimipramine. Five case histories of patients with previously non-responsive obsessional disorder are summarized. All five cases were treated in hospital with a series of infusions of intravenous chlorimipramine. The drug and route of administration was extremely well tolerated with rapid and dramatic relief of obsessional symptoms as well as improvement of mood in all cases. The theoretical action of chlorimipramine is discussed as well as possible reasons why the intravenous route appears to be superior to the oral form.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6722705     DOI: 10.1177/070674378402900211

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  3 in total

1.  Canada's doctors--who they are and what they do: lessons from the CMA's 1986 manpower survey.

Authors:  O Adams
Journal:  CMAJ       Date:  1989-01-15       Impact factor: 8.262

Review 2.  Contemporary assessment and pharmacotherapy of Tourette syndrome.

Authors:  Lawrence Scahill; Gerald Erenberg; Cheston M Berlin; Cathy Budman; Barbara J Coffey; Joseph Jankovic; Louise Kiessling; Robert A King; Roger Kurlan; Anthony Lang; Jonathan Mink; Tanya Murphy; Samual Zinner; John Walkup
Journal:  NeuroRx       Date:  2006-04

3.  Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder.

Authors:  Wael Karameh Karameh; Munir Khani
Journal:  Int J Neuropsychopharmacol       Date:  2015-07-28       Impact factor: 5.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.